Martin E. Dowty

4.8k citations
57 papers · 3.0k · 2 hit papers · h-index 24

Impact in

    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 5%
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Cytokine Signaling Pathways and Interactions 10
    • Drug Transport and Resistance Mechanisms 10
    • Receptor Mechanisms and Signaling 6

Martin E. Dowty

56 papers receiving 2.9k citations

Martin E. Dowty's Hit Papers

The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. 2016 · 305 citations
3050+5+10Years since publication100200300400500

Peers

Martin E. Dowty
Comparison fields: 5 of 110
  • Rheumatology 783
  • Immunology 750
  • Pharmacology 305
  • Hematology 389
  • Dermatology 267
Replace Thomas T. Kawabata with:
Thomas T. Kawabata United States
Cheryl Nickerson‐Nutter United States
Janet A. Houghton United States
Akari Suzuki Japan
Jacques Jolivet Canada
Susan L. Kelley United States
Steven G. Nadler United States
Ernest Brahn United States
Kah Keng Wong Malaysia
Noriaki Inamura Japan
Martin E. Dowty relative to Thomas T. Kawabata United States Thomas T. Kawabata's profile →
Citations per field
00.5×3.1×
Thomas T. Kawabata · 1×
Citations per year

Countries citing papers authored by Martin E. Dowty

Since Specialization
Citations

This map shows the geographic impact of Martin E. Dowty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin E. Dowty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin E. Dowty more than expected).

Fields of papers citing papers by Martin E. Dowty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin E. Dowty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin E. Dowty. The network helps show where Martin E. Dowty may publish in the future.

Co-authors

The 25 scholars most cited alongside Martin E. Dowty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin E. Dowty Line = papers co-authored together Martin E. Dowty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Hit paper breakdown →
2011514
2 2010384
3
The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.
Hit paper breakdown →
2016305
4 1995214
5 2014212
6 1992165
7 200795
8 201388
9 200083
10 201981
11 199278
12 202174
13 201771
14 201670
15 199945
16 200944
17 201232
18 202132
19 201631
20 199928

About Martin E. Dowty

Martin E. Dowty is a scholar working on Oncology, Molecular Biology, Pharmacology, Immunology and Pediatrics, Perinatology and Child Health, having authored 57 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Cytokine Signaling Pathways and Interactions (10 papers), Drug Transport and Resistance Mechanisms (10 papers), Rheumatoid Arthritis Research and Therapies (8 papers), Biosimilars and Bioanalytical Methods (8 papers), Dermatology and Skin Diseases (6 papers), Receptor Mechanisms and Signaling (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Rheumatology (783 citations), Immunology (750 citations), Pharmacology (305 citations), Hematology (389 citations) and Dermatology (267 citations). Martin E. Dowty has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Sriram Krishnaswami, Michael I. Jesson, Nandini Kishore, Debra M. Meyer, Jon A. Wolff, Phillip Williams, Sujatha Menon, Jean‐Baptiste Telliez, James E. Hagstrom and Sarbani Ghosh. Their work appears in journals such as Drug Metabolism and Disposition, The Journal of Clinical Pharmacology, Pharmaceutical Research, British Journal of Clinical Pharmacology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact